Published in Natl Cancer Inst Monogr on May 01, 1978
Differentiation between virulent and avirulent strains of Rickettsia prowazekii by macrophage-like cell lines. Infect Immun (1982) 1.32
Macrophages: progress and problems. Clin Exp Immunol (1981) 0.85
Induction by dimethyl sulfoxide of Fc fragment-mediated phagocytosis in the mouse macrophage-like cell line P388D1. Proc Natl Acad Sci U S A (1982) 0.84
Roles of the Fc receptor and respiratory burst in killing of Rickettsia prowazekii by macrophagelike cell lines. Infect Immun (1989) 0.83
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest (1997) 7.58
Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J Immunol (1975) 7.00
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell (1991) 6.49
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature (2000) 5.86
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity (1996) 5.64
Murine B cell leukemia line with inducible surface immunoglobulin expression. J Immunol (1978) 4.93
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol (1985) 3.62
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature (1975) 3.43
Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (1987) 3.37
Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow orgin. Nature (1974) 3.15
Polyribosomes of growing bacteria. Science (1967) 2.82
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Differences in the surface proteins of mouse B and T cells. Proc Natl Acad Sci U S A (1975) 2.78
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 2.77
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol (1977) 2.67
Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 2.40
Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol (1999) 2.34
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia (2001) 2.30
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol (2001) 2.28
Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med (1997) 2.22
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol (1992) 2.09
Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol (1986) 2.04
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med (1978) 1.94
Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood (1998) 1.93
Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J Immunol (1991) 1.92
The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J Immunol (1973) 1.90
Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol (1983) 1.88
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent. J Exp Med (1976) 1.86
Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A (1990) 1.86
In sickness and in health: Corneal epithelial stem cell biology, pathology and therapy. Exp Eye Res (2009) 1.71
Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1. J Immunol (1991) 1.71
Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol (1987) 1.71
Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood (1995) 1.69
Functional subsets of murine and human B lymphocyte cell lines. Immunol Rev (1979) 1.69
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood (1996) 1.63
Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol (1991) 1.62
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science (1978) 1.60
Lymphosarcoma cell growth is selectively inhibited by B lymphocyte mitogens: LPS, dextran sulfate and PPD. Biochem Biophys Res Commun (1974) 1.60
CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol (1998) 1.60
Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.60
Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun (1999) 1.56
Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin. J Immunol (1973) 1.56
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55
Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants. J Natl Cancer Inst (1972) 1.55
SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells (1994) 1.54
Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. J Immunol (1984) 1.54
Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture. Cancer Res (1977) 1.53
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51
Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol Cell Biol (1998) 1.50
Hematopoietic defects in mice lacking the sialomucin CD34. Blood (1996) 1.46
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester. Cell Immunol (1982) 1.44
Cloning and characterization of exodus, a novel beta-chemokine. Blood (1997) 1.44
Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency. J Clin Immunol (1984) 1.44
Mzf1 controls cell proliferation and tumorigenesis. Genes Dev (2001) 1.43
Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors. J Immunol (1981) 1.43
Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood (1998) 1.42
Leukemia viruses associated with mouse myeloma cells. Proc Natl Acad Sci U S A (1970) 1.40
Inducible production of human macrophage growth factor, CSF-1. Blood (1986) 1.40
Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med (2000) 1.38
Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun (2000) 1.37
Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem (1995) 1.34
Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene (2006) 1.33
Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera. J Exp Med (1978) 1.32
All classes of murine IgG antibody mediate macrophage phagocytosis and lysis of erythrocytes. J Immunol (1980) 1.29
Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood (1994) 1.29
Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol (1983) 1.29
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha. J Immunol (1992) 1.28
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med (1994) 1.26
Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. Exp Hematol (1977) 1.26
Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol (1987) 1.26
Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood (2000) 1.26
Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells. J Leukoc Biol (1999) 1.24
Oncogenic transformation of murine lymphoid cells by in vitro infection with Abelson leukemia virus. J Natl Cancer Inst (1975) 1.24
Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M07e cells. Blood (1994) 1.22